Xue Du

Plasma C18:0‐ceramide is a novel potential biomarker for disease severity in myasthenia gravis

Yong Zhang, Xiaoyu Huang, Yingying Wang, 2023, Journal of neurochemistry.

Circulating miRNAs drive personalized medicine based on subgroup classification in myasthenia gravis patients.

Yong Zhang, Xiaoyu Huang, Yingying Wang, 2023, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

Refractory generalized myasthenia gravis treated successfully with telitacicept: two cases report

Xiaoyu Huang, Zhouao Zhang, Xue Du, 2023, Journal of neurology.

Increased serum interleukin-41 correlates with disease severity in myasthenia gravis.

Xiaoyu Huang, Zhouao Zhang, Xue Du, 2024, International immunopharmacology.